FIGS, Inc. (NYSE:FIGS) is renowned for its innovative healthcare apparel, primarily catering to medical professionals. Despite its current trading price of $15.45, analysts have set a target price of $8.59, suggesting a potential downside of -44.39%. This significant gap reflects a lack of confidence from investment analysts, leading to its exclusion from coverage.
In comparison, Carter's, Inc. (CRI) is performing better among FIGS' peers. With a current price of $33.55 and a target price of $35.84, Carter's has a growth potential of +6.81%. This positive outlook is supported by its market cap of $1.22 billion and an earnings per share (EPS) of $2.46, indicating a stable financial position.
Gentherm Incorporated (THRM) presents a different scenario. Trading at $33.00, its target price is lower at $28.14, resulting in a negative growth potential of -14.72%. Despite a market cap of $1.01 billion, its EPS of $0.99 suggests limited profitability compared to Carter's, highlighting the varied performance within FIGS' peer group.
Albany International Corp. (AIN) shows minimal growth potential with a current price of $58.27 and a target price of $58.19, indicating a slight decline of -0.15%. Its market cap stands at $1.72 billion, but a negative EPS of -$1.81 raises concerns about its profitability, contrasting with Carter's positive financial metrics.
Overall, while FIGS faces a challenging outlook, Carter's, Inc. emerges as a more promising investment among its peers, with the highest growth potential and solid financial indicators.
